ClinicalTrials.Veeva

Menu

Preliminary Outcomes of Sacral Neuromodulation Applications; Tertiary-Center Experience in Turkey

C

Cigli Regional Training Hospital

Status

Completed

Conditions

Sacral Neuromodulation

Treatments

Device: sacral neuromodulation

Study type

Observational

Funder types

Other

Identifiers

NCT06098963
CigliRTH

Details and patient eligibility

About

to report our patients' outcomes of SNM in tertiary health centres in Turkey

Full description

We retrospectively analyzed 18 patients who underwent SNM for urinary or bowel dysfunction between 2017 and 2022 in our clinic. We excluded 2 patients due to non-effective responses after the test period. After local ethics committee approval was obtained from our institute (Number and date: 21-12.1T/14). Patient characteristics and demographic data including age, gender, indications to the SNM, age at diagnosis, and comorbidities were collected from our Hospital patients' record system. Urinary functions were evaluated by the ICIQ-SF questionnaire form. Patients' diagnosis, implantation duration, complications, and improvement of symptoms were recorded.

Enrollment

16 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with urinary incontinence
  • Patients diagnosed with faecal incontinence
  • Patients diagnosed with interstitial cystitis

Exclusion criteria

  • Presence of urinary infection
  • Presence of previous incontinence surgery
  • Presence of 2nd motor neurone disease
  • Inability of detrusor muscle contraction activity
  • Previous radical cystoprostatectomy history
  • Presence of bladder outlet obstruction

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems